Clinical trial
Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for…
NCT00001577 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001577 |
|---|---|
| Title | Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity |
| Official title | Pilot Study of a Double Isolation Perfusion Schedule Using Melphalan Alone for Intransit Melanoma or Unresectable Sarcoma of the Extremity |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Melanoma, Sarcoma |
| Intervention type | Procedure |
| Interventions | double isolated limb perfusion with melphalan alone |
| Enrollment | 30 |
| Start date | Jun 1, 1997 |
| Completion | Mar 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: